MEDICONOS
ActiveSummary
MEDICONOS has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €234,192 and a net result of €24,779. Equity is growing by about 6.2% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- MEDICONOS
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région de Bruxelles-Capitale, Annexes du Moniteur belge” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Administrateur, sauf décision contraire de l'assemblée générale” (deed in French)1 more provision on this in the deed
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed
- Authorised capitalThe amount by which the board may raise capital without a new shareholder decision.
- One provision in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Saturday of June at 10:00
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Problématiques médicales:dossiers médicaux,vie privée patients,secret professionnel, proportion actions possédées” (deed in French)